Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance
- 1 February 2015
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 93 (3) , 305-317
Abstract
No abstract availableKeywords
Funding Information
- The Cancer Society of New Zealand (11.25)
- Genesis Oncology Trust (GOT-0931-PGS)
This publication has 50 references indexed in Scilit:
- The Curcumin Analog EF24 Targets NF-κB and miRNA-21, and Has Potent Anticancer Activity In Vitro and In VivoPLOS ONE, 2013
- Modulation of multidrug resistance 1 expression and function in retinoblastoma cells by curcuminJournal of Pharmacology and Pharmacotherapeutics, 2013
- Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAsBMC Cancer, 2012
- In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin AnalogPLOS ONE, 2012
- Curcumin uptake and metabolismBioFactors, 2012
- Adjuvant treatments for triple-negative breast cancersAnnals of Oncology, 2012
- Discovery of curcumin, a component of golden spice, and its miraculous biological activitiesClinical and Experimental Pharmacology and Physiology, 2011
- Membrane Drug Transporters and Chemoresistance in Human Pancreatic CarcinomaCancers, 2010
- Differences in the expression of endogenous efflux transporters inMDR1‐transfected versus wildtype cell lines affect P‐glycoprotein mediated drug transportBritish Journal of Pharmacology, 2010
- Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancerDrug Metabolism Reviews, 2010